The life sciences champions: Top 5 mighty venture capital movers!

According to the report, the following are the summaries of 5 major venture capitalists involved in biotech.
1. Arch Venture Partners
– Founded in 1986
– The company has roughly $9 billion under management as of 2022
– The firm has backed big names such as Juno Therapeutics, Neumora Therapeutics, and Illumina.
– Recently led rounds including a $60 million Series A closed by Gate Bioscience.
1. Flagship Pioneering
– Founded in 1999
– It raised $3.4 billion in 2021, raising Flagship’s assets under management to $14.1 billion.
– Set up the famed mRNA developer Moderna.
– Its recent investments are $140 million Series B round closed by Harbinger Health and a $273 million Series C round bagged by Generate Biomedicines.
1. OrbiMed
– Established as a money-management and research firm in 1989
– One of the biggest healthcare-focused investment firms in the world, with more than $17 billion in assets under management
– Portfolio companies are liquid biopsy developer Guardant Health, and cell-free DNA testing company Natera.
1. RA Capital Management
– Founded in 2002
– $10 billion in assets under management
– One of RA Capital’s portfolio successes is the Flagship Pioneering-founded Moderna.
– Recently participated in a $105 million Series C round raised by Alentis Therapeutics and an $85 million Series A round for Rampart Bioscience.
1. Versant Ventures
– Established in 1999
– Manages approximately $4.2 billion in assets
– Recently joined Arch in backing Gate Bioscience’s Series A round.